NCT00304499View on ClinicalTrials.gov

Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence

PHASE3CompletedINTERVENTIONAL

Enrollment

176

Participants

Timeline

Start Date

December 31, 1995

Study Completion Date

December 31, 1996

Conditions

Urinary Incontinence

Interventions

DRUG

Oxybutynin

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY

NCT00304499 - Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence | Biotech Hunter | Biotech Hunter